The development for emerging biomarkers of lymphangioleiomyomatosis
Sign Up to like & getrecommendations! Published in 2024 at "Orphanet Journal of Rare Diseases"
DOI: 10.1186/s13023-024-03455-9
Abstract: Lymphangioleiomyomatosis (LAM) is a rare, slowly progressing, low-grade metastatic tumor primarily affecting women. Currently, vascular endothelial growth factor–D (VEGF-D) is the only validated diagnostic biomarker, enabling diagnosis of LAM without the need for lung biopsy… read more here.
Keywords: lam; lam lam; development emerging; biomarkers lymphangioleiomyomatosis ... See more keywords